Death of Kevin Acosta: the tragedy that reopens the debate on the healthcare system and state responsibility

TL;DR

Kevin Arley Acosta Pico, a seven-year-old boy with severe hemophilia A, died on February 13, 2026, due to an uncontrollable hemorrhage after a bicycle accident.
His condition worsened due to the delayed access to Emicizumab, a vital medication for his condition, which he had not received for over two months.
His mother, Katherine Pico, denounced that Nueva EPS failed to guarantee the timely delivery of the medication and also caused delays in his transfer from Huila.
President Gustavo Petro and Minister of Health Guillermo Alfonso Jaramillo's statements emphasizing parental prevention and restricting children's activities were met with strong criticism.
Medical experts and patient organizations argued that true prevention in hemophilia lies in ensuring continuous access to treatment, allowing children to lead normal lives.
The case highlighted the structural problems within the Colombian healthcare system, particularly concerning the Nueva EPS and its continuous treatment guarantees.
The Minister of Health assured that the case would be thoroughly investigated to establish institutional responsibilities and prevent similar tragedies.

Continuar leyendo el artículo original